Alcon has appointed Stephen (Steve) S. Lane as chief medical officer and global head of franchise clinical strategy, effective June 1. In his new role, he will lead the integration of clinical, scientific and commercial priorities across Alcon's surgical and vision care franchises. He will also represent Alcon to the scientific and industry communities, and government agencies. Lane has a 32-year experience as a specialist in cataract surgery, anterior segment surgery, LASIK, refractive surgery, and cornea/external diseases. He is the past president of the American Society of Cataract Surgeons (ASCRS), and currently serves on the editorial boards of several ophthalmic journals. He is also an adjunct professor of ophthalmology at the University of Minnesota, co-chair of the ASCRS Foundation, and a visiting faculty member of ORBIS International, an Alcon partner. In addition to the numerous awards he has received throughout his career, Lane has been recognized in the top 1 percent of ophthalmologists by U.S. News.